01 Jun Semaglutide vs. Tirzepatide: Which GLP-1 Weight Loss Medication Is Right for You?
If you’ve been researching prescription weight loss, two names come up over and over: semaglutide (brand names Ozempic and Wegovy) and tirzepatide (brand names Mounjaro and Zepbound). They are both injected once a week. They both reduce appetite. They both deliver meaningful weight loss for many patients. But they are not interchangeable. Here is how they actually compare.
At-a-Glance Comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Drug class | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Brand names | Ozempic, Wegovy | Mounjaro, Zepbound |
| FDA-approved for weight loss | Yes (Wegovy) | Yes (Zepbound) |
| Dosing | Once weekly injection | Once weekly injection |
| Average weight loss in clinical trials | About 15% of body weight at 68 weeks | About 21% of body weight at 72 weeks |
| Common side effects | Nausea, vomiting, diarrhea, constipation | Same profile, sometimes milder |
| Typical titration | 5 dose increases over 16+ weeks | 5 dose increases over 20+ weeks |
Numbers cited above come from the STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide) clinical trials. Your individual results may differ.
How Each One Works
Both medications mimic gut hormones your body produces naturally after a meal. Those hormones tell your brain you are full and slow how quickly food leaves your stomach. The result is that you eat less without feeling deprived.
The key difference is that tirzepatide targets two hormones (GIP and GLP-1) while semaglutide targets only GLP-1. The dual action is the most likely reason tirzepatide showed greater average weight loss in trial data, though individual response varies and many patients do exceptionally well on semaglutide.
When Semaglutide Tends to Be the Better Fit
- You have a history of GI sensitivity and want to start with a single-target medication
- You qualify for Wegovy coverage through insurance and tirzepatide is not covered
- You have type 2 diabetes and benefit from semaglutide’s longer track record at this point
- Your initial weight loss goal is moderate (10 to 15 percent of body weight)
When Tirzepatide Tends to Be the Better Fit
- You have more significant weight to lose and want the most potent option available
- You did not get the response you wanted on semaglutide
- You have insulin resistance or prediabetes alongside obesity
The right choice is almost always determined in a consultation, not online. Your medical history, current medications, insurance situation, and personal preference all play into it. At Get Skinny Jax, we discuss both options during your free consultation so you can make an informed decision.
Side Effects: What to Actually Expect
For both medications, the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation. These usually appear in the first few weeks after a dose increase and ease as your body adjusts. A slow titration schedule and dietary adjustments (smaller meals, less greasy food, staying hydrated) handle the majority of cases.
Less common but more serious effects can include pancreatitis, gallbladder issues, and severe nausea that prevents adequate nutrition. Both medications carry a boxed warning related to thyroid C-cell tumors observed in animal studies, which is why a personal or family history of medullary thyroid carcinoma or MEN2 syndrome is a contraindication for both.
Cost and Access in Jacksonville
Cash-pay programs through medical weight loss clinics typically bundle the medication, provider visits, and supportive supplements together. Get Skinny Jax offers both tirzepatide and semaglutide programs in Jacksonville, with the choice driven by what fits your medical profile and goals rather than by inventory.
Frequently Asked Questions
Can I switch from semaglutide to tirzepatide?
Yes. Many patients do. The switch is supervised by your provider so dosing starts at the lower end and titrates up again to manage side effects.
Which one has fewer side effects?
In clinical trials the side effect profiles are similar. In practice, some patients tolerate one better than the other for individual reasons. Your provider will adjust titration speed and dose to your tolerance.
Do I have to stay on either one forever?
Not necessarily, but stopping without a plan is the main reason for weight regain. A maintenance plan, typically a lower dose or longer interval, is part of long-term success.
Which one is FDA approved for weight loss specifically?
Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA approved for chronic weight management. Ozempic and Mounjaro are approved for type 2 diabetes but are often prescribed off-label for weight loss.
This article is informational and not a substitute for medical advice. Talk to a licensed provider before starting any prescription medication.